Last reviewed · How we verify
MLD10
At a glance
| Generic name | MLD10 |
|---|---|
| Also known as | elemental magnesium |
| Sponsor | Pharmalyte Solutions LLC |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- MLD10 for the Treatment of Hypomagnesemic Patients With Type 2 Diabetes Mellitus (PHASE2)
- MLD10 in the Prevention of Migraine in Adults (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |